The renin-angiotensin system is a complex biochemical pathway that maintains homeostasis of blood pressure, blood volume and electrolyte composition. The active product of this pathway, angiotensin II, has effects on tissues throughout the body. Studies have demonstrated that virtually all of the physiologic actions of angiotensin II are mediated by the AT1 receptor. It is remarkable that angiotensin II binding to the identical receptor in the adrenal, the kidney, the liver and vascular smooth muscle cells causes such a diversity of tissue specific effects. This clearly suggests that the angiotensin II-AT1 receptor association is only the first step in a cascade of intracellular signals that progresses from the cell surface into the cytoplasm and the nucleus. It is these signals that stimulate tissue specific responses. Recently, it has become clear that tyrosine phosphorylation plays an important role in the early signalling responses mediated by angiotensin II. This grant is to study how angiotensin II, in binding to the seven-transmembrane AT1 receptor, stimulates the tyrosine phosphorylation of downstream kinases and heterotrimeric G-proteins in angiotensin II mediated tyrosine phosphorylation of phospholipase C, the JAK pathway and the Ras signaling pathways.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK044280-08
Application #
2872198
Study Section
General Medicine B Study Section (GMB)
Project Start
1992-02-01
Project End
2001-01-31
Budget Start
1999-02-01
Budget End
2000-01-31
Support Year
8
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Emory University
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Gletsu, Nana; Doan, Thanh N; Cole, Justin et al. (2005) Angiotensin II-induced hypertension in mice caused an increase in insulin secretion. Vascul Pharmacol 42:83-92
Xiao, Hong D; Fuchs, Sebastien; Frenzel, Kristen et al. (2004) The use of knockout mouse technology to achieve tissue selective expression of angiotensin converting enzyme. J Mol Cell Cardiol 36:781-9
Fuchs, Sebastien; Xiao, Hong D; Cole, Justin M et al. (2004) Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice. J Biol Chem 279:15946-53
Xiao, Hong D; Fuchs, Sebastien; Campbell, Duncan J et al. (2004) Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 165:1019-32
Xiao, Hong D; Fuchs, Sebastien; Frenzel, Kristen et al. (2004) Circulating versus local angiotensin II in blood pressure control: lessons from tissue-specific expression of angiotensin-converting enzyme (ACE). Crit Rev Eukaryot Gene Expr 14:137-45
Campbell, Duncan J; Alexiou, Theodora; Xiao, Hong D et al. (2004) Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension 43:854-9
Weiss, Sharon; Doan, Thanh; Bernstein, Kenneth E et al. (2004) Modulation of cardiac Ca2+ channel by Gq-activating neurotransmitters reconstituted in Xenopus oocytes. J Biol Chem 279:12503-10
Xiao, Hong D; Fuchs, Sebastien; Frenzel, Kristen et al. (2003) Newer approaches to genetic modeling in mice: tissue-specific protein expression as studied using angiotensin-converting enzyme (ACE). Am J Pathol 163:807-17
Cole, Justin M; Xiao, Hong; Adams, Jonathan W et al. (2003) New approaches to genetic manipulation of mice: tissue-specific expression of ACE. Am J Physiol Renal Physiol 284:F599-607
Cole, Justin M; Khokhlova, Nata; Sutliff, Roy L et al. (2003) Mice lacking endothelial ACE: normal blood pressure with elevated angiotensin II. Hypertension 41:313-21

Showing the most recent 10 out of 44 publications